ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 98 filers reported holding ASCENDIS PHARMA A/S in Q3 2018. The put-call ratio across all filers is 1.39 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $30,713 | -87.6% | 328 | -88.2% | 0.00% | -87.5% |
Q2 2023 | $247,847 | +134599.5% | 2,777 | +61.5% | 0.01% | +33.3% |
Q1 2023 | $184 | -24.9% | 1,719 | -14.3% | 0.01% | -40.0% |
Q4 2022 | $245 | -99.8% | 2,005 | +96.0% | 0.01% | +400.0% |
Q3 2022 | $106,000 | -72.2% | 1,023 | -75.0% | 0.00% | -77.8% |
Q2 2022 | $381,000 | +27.4% | 4,094 | +60.9% | 0.01% | +200.0% |
Q1 2022 | $299,000 | -33.3% | 2,545 | -23.5% | 0.00% | -62.5% |
Q4 2021 | $448,000 | +293.0% | 3,325 | +364.4% | 0.01% | +166.7% |
Q3 2021 | $114,000 | -69.1% | 716 | -74.5% | 0.00% | -70.0% |
Q2 2021 | $369,000 | +1319.2% | 2,805 | +1316.7% | 0.01% | – |
Q1 2021 | $26,000 | -68.7% | 198 | -60.2% | 0.00% | -100.0% |
Q4 2020 | $83,000 | +130.6% | 498 | +114.7% | 0.00% | – |
Q3 2020 | $36,000 | -93.7% | 232 | -94.0% | 0.00% | -100.0% |
Q2 2020 | $567,000 | +990.4% | 3,838 | +736.2% | 0.02% | +666.7% |
Q1 2020 | $52,000 | -50.9% | 459 | -49.9% | 0.00% | -57.1% |
Q2 2019 | $106,000 | -38.7% | 916 | -37.9% | 0.01% | -30.0% |
Q1 2019 | $173,000 | +2062.5% | 1,476 | +1183.5% | 0.01% | – |
Q2 2018 | $8,000 | +700.0% | 115 | +784.6% | 0.00% | – |
Q1 2018 | $1,000 | -50.0% | 13 | -77.2% | 0.00% | – |
Q3 2017 | $2,000 | – | 57 | – | 0.00% | – |
Q2 2017 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q1 2017 | $32,000 | +166.7% | 1,133 | +86.0% | 0.00% | +200.0% |
Q4 2016 | $12,000 | -29.4% | 609 | -27.4% | 0.00% | -50.0% |
Q3 2016 | $17,000 | -19.0% | 839 | -47.5% | 0.00% | 0.0% |
Q2 2016 | $21,000 | +600.0% | 1,599 | +813.7% | 0.00% | – |
Q3 2015 | $3,000 | – | 175 | +1066.7% | 0.00% | – |
Q2 2015 | $0 | -100.0% | 15 | -98.9% | 0.00% | -100.0% |
Q1 2015 | $23,000 | – | 1,323 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |